At the Thirteenth International Kidney Cancer Symposium, Dr Hans Hammers (Johns Hopkins, MD) encourages kidney cancer patients to take an active role in health care. Currently, a strategic and patient-tailored approach is recommended in kidney cancer management. Dr Hammers discusses how clinical trials represent opportunities for patients to access new medicines and further therapy development.